Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

ClinicalTrials.gov ID: NCT06736509

Public ClinicalTrials.gov record NCT06736509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this open-label extension trial was to evaluate the long-term safety of AXS-05 for the treatment of Alzheimer's disease agitation in subjects that participated in ADVANCE-2 or ACCORD-2.

Study identification

NCT ID
NCT06736509
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
139 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2024
Primary completion
Feb 16, 2025
Completion
Apr 24, 2025
Last update posted
Jun 24, 2026

2024 – 2025

United States locations

U.S. sites
21
U.S. states
8
U.S. cities
16
Facility City State ZIP Site status
Clinical Research Site Peoria Arizona 85381
Clinical Research Site Walnut Creek California 94596
Clinical Research Site Bonita Springs Florida 34134
Clinical Research Site Brandon Florida 33511
Clinical Research Site Greenacres City Florida 33467
Clinical Research Site Hialeah Florida 33012
Clinical Research Site Miami Florida 33126
Clinical Research Site Miami Florida 33145
Clinical Research Site Miami Florida 33155
Clinical Research Site Miami Florida 33165
Clinical Research Site Miami Florida 33173
Clinical Research Site Miami Gardens Florida 33014
Clinical Research Site Miami Lakes Florida 33014
Clinical Research Site Pembroke Pines Florida 33025
Clinical Research Site Tampa Florida 33614
Clinical Research Site Tampa Florida 33634
Clinical Research Site Braintree Massachusetts 02184
Clinical Research Site Brooklyn New York 11229
Clinical Research Site Charlotte North Carolina 28211
Clinical Research Site Mesquite Texas 75149
Clinical Research Site Arlington Virginia 22205

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06736509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06736509 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →